mifepristone has been researched along with Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debu, E; Dufour, B; Fontan, JE; Langlade, A; Majorel, P; Scheller, E; Weber, B | 1 |
| Cooke, ID; Dockery, P; Li, TC; Rogers, AW | 1 |
| Watanabe, ME | 1 |
| Baton Saint-mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| He, X; Liao, D; Tan, B; Xin, H | 1 |
11 other study(ies) available for mifepristone and Disease
| Article | Year |
|---|---|
[Abortion induced by mifepristone and sulprostone combination: attempting analgesia with acetominophen or dipropyline].
Topics: Abortion, Induced; Analgesia; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Family Planning Services; France; Hormone Antagonists; Hormones; Mifepristone; Pain; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Prostaglandins, Synthetic; Reproduction; Research; Signs and Symptoms; Therapeutics; Time Factors | 1990 |
Histological and clinical features of menstruation induced by the antiprogestin mifepristone (RU486) compared to menstruation occurring spontaneously.
Topics: Biology; Cell Biology; Clinical Laboratory Techniques; Developed Countries; Diagnosis; Disease; Endocrine System; Endometrium; England; Europe; Genitalia; Genitalia, Female; Hemorrhage; Histology; Hormone Antagonists; Hormones; Human Experimentation; Menstrual Cycle; Menstruation; Mifepristone; Physiology; Reproduction; Research; Signs and Symptoms; United Kingdom; Urogenital System; Uterus | 1990 |
RU 486: an overview of mifepristone and its potential applications.
Topics: Abortifacient Agents; Abortion, Induced; Americas; Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Developed Countries; Disease; Embryo Implantation; Endocrine System; Endometrium; Europe; Family Planning Services; France; Genitalia; Genitalia, Female; Hormone Antagonists; Hormones; Labor Stage, First; Menstruation; Mifepristone; Neoplasms; North America; Ovulation; Physiology; Therapeutics; United States; Urogenital System; Uterus | 1993 |
News in contraception.
Topics: Americas; Biology; Clinical Trials as Topic; Contraception; Contraceptives, Oral; Developed Countries; Diabetes Mellitus; Disease; Endocrine System; Eye; Family Planning Services; Hormone Antagonists; Hormones; Kidney; Mifepristone; North America; Physiology; Research; Retina; United States; Urogenital System | 1994 |
RU 486 research forges on, despite political hurdles.
Topics: Adrenal Cortex; Americas; Biology; Breast Neoplasms; Central Nervous System; Clinical Trials as Topic; Developed Countries; Disease; Economics; Endocrine Glands; Endocrine System; Evaluation Studies as Topic; Financial Management; Financing, Government; Genitalia; Genitalia, Female; Hormone Antagonists; Hormones; Mifepristone; Neoplasms; North America; Physiology; Politics; Prejudice; Research; Social Problems; United States; Urogenital System; Uterus | 1994 |
RU 486 approved in Britain; U.S. research still limited.
Topics: Abortifacient Agents; Abortion, Induced; Americas; Biology; Breast Neoplasms; Consumer Product Safety; Developed Countries; Disease; Endocrine System; Europe; Family Planning Services; France; Hormone Antagonists; Hormones; Legislation as Topic; Mifepristone; Neoplasms; North America; Physiology; Prostaglandins; Scandinavian and Nordic Countries; United Kingdom; United States | 1991 |
[Inducing embryo expulsion in women with spontaneous fetal death in the first trimester. Use of mifepristone (RU-486) in a prospective, randomized, double blind study].
Topics: Abortion, Spontaneous; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Fetal Death; France; Hormone Antagonists; Hormones; Mifepristone; Mortality; Physiology; Population; Population Dynamics; Pregnancy Complications; Research | 1993 |
Who's trying to scare women?
Topics: Abortion, Induced; Americas; Attitude; Behavior; Biology; Breast Neoplasms; Canada; Contraception; Developed Countries; Disease; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Hormone Antagonists; Hormones; Jurisprudence; Mifepristone; Neoplasms; North America; Physiology; Politics; Psychology; Public Opinion; United States | 1996 |
Overview.
Topics: Abortion, Induced; Americas; Biology; Consumer Product Safety; Demography; Developed Countries; Disease; Education; Endocrine System; Family Planning Services; Fertility; Health Education; HIV Infections; Hormone Antagonists; Hormones; Informed Consent; Legislation as Topic; Licensure; Mifepristone; North America; Physiology; Population; Population Dynamics; Pregnancy in Adolescence; Sex Education; Sexual Behavior; Third-Party Consent; United States; Virus Diseases | 1993 |
Comparing the effectiveness of different doses of mifepristone.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormone Antagonists; Hormones; Menstruation Disturbances; Mifepristone; Physiology; Research; Signs and Symptoms | 1999 |
Studies on relationship between serum nitric oxide and plasma cyclic guanosine monophosphate and prolonged bleeding after medical abortion as well as prophylaxis and treatment of bleeding with traditional Chinese medicine.
Topics: Abortion, Induced; Asia; Asia, Eastern; Biology; Chemical Phenomena; Chemistry; China; Developing Countries; Disease; Endocrine System; Enzymes; Family Planning Services; Hemorrhage; Hormone Antagonists; Hormones; Inorganic Chemicals; Mifepristone; Physiology; Research; Signs and Symptoms; Therapeutics | 1999 |